Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

697 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Rationale, design, methods and baseline demography of participants of the Anglo-Scandinavian Cardiac Outcomes Trial. ASCOT investigators.
Sever PS, Dahlöf B, Poulter NR, Wedel H, Beevers G, Caulfield M, Collins R, Kjeldsen SE, McInnes GT, Mehlsen J, Nieminen M, O'Brien E, Ostergren J. Sever PS, et al. Among authors: kjeldsen se. J Hypertens. 2001 Jun;19(6):1139-47. doi: 10.1097/00004872-200106000-00020. J Hypertens. 2001. PMID: 11403364 Clinical Trial.
Anglo-Scandinavian Cardiac Outcomes Trial: a brief history, rationale and outline protocol.
Sever PS, Dahlöf B, Poulter NR, Wedel H, Beevers G, Caulfield M, Collins R, Kjeldsen SE, McInnes GT, Mehlsen J, Nieminen M, O'Brien E, Ostergren J; ASCOT Steering Committee, Anglo-Scandinavian Cardiac Outcomes Trial. Sever PS, et al. Among authors: kjeldsen se. J Hum Hypertens. 2001 Aug;15 Suppl 1:S11-2. doi: 10.1038/sj.jhh.1001212. J Hum Hypertens. 2001. PMID: 11685901 No abstract available.
Characteristics of 9194 patients with left ventricular hypertrophy: the LIFE study. Losartan Intervention For Endpoint Reduction in Hypertension.
Dahlöf B, Devereux RB, Julius S, Kjeldsen SE, Beevers G, de Faire U, Fyhrquist F, Hedner T, Ibsen H, Kristianson K, Lederballe-Pedersen O, Lindholm LH, Nieminen MS, Omvik P, Oparil S, Wedel H. Dahlöf B, et al. Among authors: kjeldsen se. Hypertension. 1998 Dec;32(6):989-97. doi: 10.1161/01.hyp.32.6.989. Hypertension. 1998. PMID: 9856962 Clinical Trial.
Lowering of blood pressure and predictors of response in patients with left ventricular hypertrophy: the LIFE study. Losartan Intervention For Endpoint.
Kjeldsen SE, Dahlöf B, Devereux RB, Julius S, de Faire U, Fyhrquist F, Ibsen H, Kristianson K, Lederballe-Pedersen O, Lindholm LH, Nieminen MS, Omvik P, Oparil S, Wedel H. Kjeldsen SE, et al. Am J Hypertens. 2000 Aug;13(8):899-906. doi: 10.1016/s0895-7061(00)00280-6. Am J Hypertens. 2000. PMID: 10950398 Clinical Trial.
Alcohol consumption and cardiovascular risk in hypertensives with left ventricular hypertrophy: the LIFE study.
Reims HM, Kjeldsen SE, Brady WE, Dahlöf B, Devereux RB, Julius S, Beevers G, De Faire U, Fyhrquist F, Ibsen H, Kristianson K, Lederballe-Pedersen O, Lindholm LH, Nieminen MS, Omvik P, Oparil S, Wedel H. Reims HM, et al. Among authors: kjeldsen se. J Hum Hypertens. 2004 Jun;18(6):381-9. doi: 10.1038/sj.jhh.1001731. J Hum Hypertens. 2004. PMID: 15103313 Clinical Trial.
The effect of losartan compared with atenolol on the incidence of revascularization in patients with hypertension and electrocardiographic left ventricular hypertrophy. The LIFE study.
Olsen MH, Wachtell K, Dahlöf B, Devereux RB, Ibsen H, Kjeldsen SE, Lindholm LH, Lyle PA, Nieminen MS. Olsen MH, et al. Among authors: kjeldsen se. J Hum Hypertens. 2006 Jun;20(6):460-4. doi: 10.1038/sj.jhh.1002013. J Hum Hypertens. 2006. PMID: 16572193 Clinical Trial. No abstract available.
Antihypertensive treatment and risk of cancer: an individual participant data meta-analysis.
Copland E, Canoy D, Nazarzadeh M, Bidel Z, Ramakrishnan R, Woodward M, Chalmers J, Teo KK, Pepine CJ, Davis BR, Kjeldsen S, Sundström J, Rahimi K; Blood Pressure Lowering Treatment Trialists' Collaboration. Copland E, et al. Lancet Oncol. 2021 Apr;22(4):558-570. doi: 10.1016/S1470-2045(21)00033-4. Lancet Oncol. 2021. PMID: 33794209 Free PMC article.
697 results